Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

Share Price is delayed by 15 minutes
Get Live Data
32.00    -0.75 (-2.29%)
Bid:
31.00
Ask:
33.00
Spread: 2.00 (6.452%)
Market Cap: £57.87m
IKA Live PriceLast checked at - London Stock Exchange

Intraday Ilika Plc Share Chart

Goliath Scale-up Update

4 May 2022 07:00

RNS Number : 1690K
Ilika plc
04 May 2022
 

Ilika plc

("Ilika" or the "Company")

 

Goliath Scale-up Update

Scale-up plans validated - highlighting cost-saving benefits at higher volume production levels

Ilika (AIM: IKA), a pioneer in solid-state battery technology, announces the successful conclusion of its scale-up study, SOLSTICE, with partner Comau, part of Stellantis, and a world leader in the industrial automation field. The study reviewed Ilika's existing Goliath pre pilot line and delivered a plant design for a Goliath manufacturing line at a mega-scale facility (the "Project"). As reported by the company on 6th April 2021, the 12-month Project was supported by the Advanced Propulsion Centre (APC) and Ilika received a £276,000 grant towards costs related to the Project.

The Project had two objectives, firstly a review and subsequent validation of Ilika's internal plan to scale up its facility from a production capacity of 50kWh per year to 2MWh per year. Following on from the review, Ilika has a detailed facility and equipment plan and has entered into discussions with equipment vendors, with the first long lead time equipment orders expected to be placed in Q2 2022. Ilika's 2MWh scale up will deliver and commission a fully operational facility by Q4 2023. In the meantime, the development of Ilika's Goliath solid-state battery technology continues in accordance with the Company's technology roadmap.

The second objective of the Project was an initial review of Ilika's defined manufacturing process to assess its suitability for megawatt scale up. The Project concluded there were no cost or technical barriers to scale up, and indeed important manufacturing benefits were identified, such as an accelerated formation stage relative to traditional lithium-ion, which has the potential to significantly reduce formation times. Comau has produced a high-level costed plant design for the megawatt scale solid-state manufacturing line which will be further refined in future planned collaborations.

Automotive Transformation Director at the APC, Julian Hetherington said: "The UK has a long legacy of automotive manufacturing success and the industry now needs to scale up, at pace, to net-zero emission technologies. We are delighted that the funding awarded to Ilika and Comau through the Automotive Transformation Fund has successfully supported collaborative product and manufacturing process development that can unlock routes to subsequent investment in scaled- up facilities."

John Coombes, managing Director of Comau UK stated: "This project represented an integral part of the Comau Journey in Electrification, developed with the contribution of the internal Battery Cells Global Competence Center. We are proud of the collaboration we have had with Ilika and the APC, and also the ability to demonstrate the value our capabilities can contribute in this field. "

Graeme Purdy, Ilika CEO, stated: "This project has successfully validated Ilika's scale-up plans for its Goliath technology, highlighting some important cost-saving benefits at higher volume production levels which pave the way to gigawatt scale manufacturing. Working with Comau, one of the world's leading designers of innovative engineering solutions, has delivered a robust plan to scale-up Ilika's manufacturing capability for Goliath solid-state batteries to the next level."

 

For more information contact:

Ilika plc

Graeme Purdy, Chief Executive

Steve Boydell, Finance Director

+44 (0)23 8011 1400

 

 

 

 

Liberum Capital Limited

Andrew Godber, Cameron Duncan,

William Hall, Nikhil Varghese

+44 (0) 20 3100 2000

 

 

 

Berenberg (Joint Broker)

Emily Morris, Detlir Elezi,

Milo Bonser, Mara Grasso

+44 (0) 20 3207 8700

 

Walbrook PR Ltd

+44 (0)20 7933 8780 or ilika@walbrookpr.com

Lianne Applegarth

Mob: +44 (0)7584 391 303

Nick Rome

Mob: +44 (0)7748 325 236

Tom Cooper

Mob: +44 (0)7971 221 972

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBKNBNPBKDKPK
Date   Source Headline
21st May 20267:00 amRNSIlika Trading Update and Notice of Results
10th Apr 20264:01 pmRNSCollaboration with Brompton Bicycles
18th Mar 20267:00 amRNSPositive Feedback on Safety of Goliath Cells
10th Mar 20267:00 amRNSFirst Commercial Delivery to Cirtec Medical
24th Feb 202610:21 amRNSAward of Share Options
19th Feb 20267:00 amRNS-RIlika at Yellowstone Investor Evening: Replacement
22nd Jan 20267:00 amRNSHalf-year Financial Report
21st Jan 20267:00 amRNSIlika Secures Stereax Electrode Order from Cirtec
18th Dec 20257:00 amRNSInitial Stereax M300 Shipments
11th Dec 20257:00 amRNSIlika Ships 10Ah Goliath Battery Prototypes
20th Nov 20257:00 amRNSTrading Update & Notice of Half-Year Results
21st Oct 20257:00 amRNSCommissioning Complete for Goliath Pilot Line
1st Oct 202512:00 pmRNSExercise of Options and Total Voting Rights
23rd Sep 20253:43 pmRNSResult of AGM & Award of Executive Share Options
22nd Sep 20257:00 amRNSStart of Primed Solid-State Battery Programme
28th Aug 20257:00 amRNSNotice of AGM and Posting of Annual Report
18th Aug 20257:00 amRNSStereax Battery Milestone at Cirtec Medical
17th Jul 20258:56 amRNSHolding(s) in Company
17th Jul 20257:00 amRNSFinal Results
15th Jul 20257:00 amRNSAward of Government Grant Funding
11th Jun 20252:09 pmRNSNotice of Results
4th Jun 20252:14 pmRNSHolding(s) in Company
3rd Jun 20251:57 pmRNSHolding(s) in Company
28th May 20256:00 pmRNSResult of Oversubscribed Retail Offer
22nd May 20252:16 pmRNSRetail Offer for up to £0.5 million
22nd May 20251:53 pmRNSResult of Placing & Director Subscription
21st May 20255:14 pmRNSProposed Capital Raise
7th May 202510:03 amRNS-RIlika announces 2025 Investor Day
1st May 20257:00 amRNSGoliath P1 Cells Validated by Customer Testing
15th Apr 20257:00 amRNSGoliath Battery Achieves Scale-up Milestone
6th Mar 20257:00 amRNSGoliath Development Progress
27th Feb 20257:00 amRNSAward & Exercise of Share Options
6th Feb 20253:49 pmRNSHolding(s) in Company
5th Feb 20257:00 amRNSGoliath Scale-up Progress
21st Jan 20257:00 amRNSHalf-year Results
9th Jan 20257:00 amRNSStereax Equipment Commissioning Completed
19th Dec 20247:00 amRNSAppointment of Nominated Adviser and Sole Broker
22nd Nov 20242:18 pmRNSAIM Rule 17 Schedule 2(g) Update
20th Nov 20247:00 amRNSGoliath D6 milestone reached
15th Nov 20247:00 amRNSTrading Update & Notice of Half-Year Results
10th Oct 20241:49 pmRNSHolding(s) in Company
3rd Oct 20247:00 amRNSFurther Goliath Technical Milestone Achieved
29th Aug 20247:00 amRNSPosting of Annual Report and Notice of AGM
11th Jul 20247:00 amRNSFinal Results
2nd Jul 20247:00 amRNSKey Technology Validation Milestone
1st Jul 20247:00 amRNSNominated Adviser and Joint Broker
31st May 20242:29 pmRNSHolding(s) in Company
29th May 202411:52 amRNSResults of General Meeting Open Offer and TVR
22nd May 20247:00 amRNSKey Goliath Technology Validation Milestone
16th May 20247:00 amRNSTrading Update, Notice of Results & Presentations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.